Recent years have been experiencing a dramatic increase in the number of Hepatitis D cases. It is spreading at a rapid rate. DelveInsight estimated that the total diagnosed Hepatitis D prevalence w...
Ikena secures USD 120 Million to advance a growing pipeline of cancer drugs Ikena Oncology has bagged USD 120 million to develop its expanding pipeline of cancer drugs. The Series B round begins as Ikena prepares to add a TEAD inhibitor to its roster of clinical programs and pushes a first-in-class KRAS asset th...
Find More
Alternative Medicine often referred to as “integrative,” or “complementary” medicine, including a wide range of medical treatments, products, practices, and health care systems that are not a part of standard/ conventional medical care. Alternative medicine is categorized together with complementary med...
Find More
The healthcare industry over the past decade has observed revolutionary changes. Technology along with human expertise has completely changed the process of prevention, diagnosis, and treatment of diseases at almost every level of the healthcare delivery system. The health system or healthcare delivery sys...
Find More
The launch of the Pipeline therapies, increasing EPI prevalence shall fuel the Exocrine pancreatic insufficiency market size estimated to be approximately USD 1,695.26 Million in 2017. A loss of acinar pancreatic cells that causes insufficient production of pancreatic enzymes in the duodenum results in Exo...
Find More
Gastroparesis, often referred to as delayed gastric emptying, is a disorder affecting the movement of food from the stomach to the small intestine. As per the National Institute of Diabetes and Digestive and Kidney Diseases, “Gastroparesis is not common. Out of 100,000 people, about 10 men and 40 women have gastrop...
Find More
The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynamic pipeline therapies in the mid-/ late-stage clinical development and rising gastroparesis prevalence. Gastroparesis or Delayed gastric emp...
Find More
Roche Set to Compete With Biogen and Novartis in the SMA Market With its First Oral Therapy The US FDA has recommended the use of Evrysdi (risdiplam), a candidate of Genentech, a Roche company, for spinal muscular atrophy (SMA), an inherited neuromuscular disease resulting in muscle atrophy, in adults and...
Find More
Orchard licenses the gene therapy technology from GlaxoSmithKline Orchard Therapeutics has permitted lentiviral stable cell line technology from GlaxoSmithKline for its use in hematopoietic stem cell gene therapies. GSK filed for patents on the tech before selling its rare disease gene therapy portfolio to...
Find More
Intercept Pharmaceuticals receives a clear rejection from the FDA for its NASH drug, Obeticholic acid (OCA) Intercept Pharmaceuticals announced the issuance of a Complete Response Letter (CRL) by the FDA regarding the New Drug Application (NDA) for Obeticholic acid (OCA) for the treatment of fibrosis due to ...
Find More
The medical device industry is a dynamic, innovative, and heterogeneous sector. The MedTech industry.....
Find More
Gene Therapy has shown tremendous growth in the past few years. The use of AAV (adeno-associated vir.....
Find More
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD.....
Find More
Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused b.....
Find More
A rare glomerular kidney-scarring disease, Focal Segmental Glomerulosclerosis (FSGS) is a disease wi.....
Find More
Digital health technologies can fill the current gaps in oncology care while rebalancing the existin.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
